Halitus

Halitus

Developing a technology that can detect diseases by analyzing a person's breath.

HQ location
Berlin, Germany
Website
Launch date
Employees
Enterprise value
$4—7m
Company register number
HRB 241233 B (Charlottenburg (Berlin))
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor

€0.0

round
*

€1.0m

Seed
Total Funding000k
Notes (0)
More about Halitus
Made with AI
Edit

Halitus, a Berlin-based health-tech company founded in 2021, is focused on developing non-invasive diagnostic technologies by analyzing biomarkers in exhaled breath. The company was established by a multidisciplinary team including Dr. Sven Jungmann, a medical doctor who also serves as CEO, alongside engineer Dr. Sergey Davydov, mathematician Matthew Grimot, and economist Sergey Repenko. This diverse expertise underpins the firm's approach to tackling complex healthcare challenges through technological solutions. The company's primary offering is an AI-supported analysis tool that utilizes laser technology and machine learning to detect disease-relevant biomarkers from breath samples.

The technology is designed to produce rapid biometric health summaries, enabling healthcare providers to identify diseases such as cancer and infectious or inflammatory conditions at an earlier stage. The device is engineered to be portable and user-friendly for application in various settings, including clinics, medical practices, and potentially public spaces like airports. In the long term, Halitus aims to provide a Software-as-a-Service (SaaS) solution that offers AI-driven interpretation and decision support for medical professionals, facilitating faster and more precise diagnostics. The company also provides comprehensive AI frameworks and cloud-based solutions compliant with regulatory standards like ISO 13485 and IEC 62304, targeting MedTech startups, established companies, and healthcare providers as its client base.

In July 2023, Halitus secured approximately €1 million in a pre-seed funding round. Key investors in this round included better ventures, Angels4Health, OKG Capital, and Infinite Digital. This capital was earmarked for the further development of its diagnostic devices, enhancement of its machine learning algorithms, and conducting initial clinical trials with partner clinics. The company's potential was recognized in 2022 when it won the digital health award from Novartis Germany. Despite these developments, some sources indicate that the company is currently inactive or has been deadpooled.

Keywords: breath analysis, medical diagnostics, health-tech, disease detection, biomarkers, non-invasive diagnostics, AI in healthcare, machine learning, laser technology, precision medicine, diagnostic equipment, MedTech, clinical decision support, SaaS in healthcare, digital health, portable medical devices, early disease detection, cancer detection, infectious disease diagnostics, inflammatory disease

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo